138 filings
8-K
MYMD
MyMD Pharmaceuticals Inc
18 Apr 24
Departure of Directors or Certain Officers
4:30pm
8-K
MYMD
MyMD Pharmaceuticals Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
8-K/A
MYMD
MyMD Pharmaceuticals Inc
26 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
MYMD
MyMD Pharmaceuticals Inc
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
MYMD
MyMD Pharmaceuticals Inc
5 Mar 24
Regulation FD Disclosure
11:00am
8-K
9idzf000gpf3 kmw
13 Feb 24
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
4:57pm
8-K
omtscic7c1m62t9c
6 Dec 23
Regulation FD Disclosure
9:15am
8-K
iqx8a7dia5e8zhx9gcj
19 Oct 23
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced
9:00am
8-K
39s xhnwuc9zlcwm77
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
opshw1rdv e5v65c1n
4 Oct 23
MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023
4:30pm
8-K
pp6yeq77cetuv1lbz
8 Sep 23
Departure of Directors or Certain Officers
5:24pm
8-K
75p9ypn054aufd7
14 Aug 23
Regulation FD Disclosure
8:30am
8-K
18q49li 7q13o6p
3 Aug 23
MyMD Pharmaceuticals Phase 2 Trial Update
4:30pm
8-K
klf74435nbfqp
1 Aug 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
sl85yyqnd2wv
31 Jul 23
MyMD Pharmaceuticals Reports Statistically Significant Positive Topline
9:00am
8-K
7i6jg mkjes
14 Jul 23
Other Events
8:30am
8-K
cz3r66et f2pw
9 Jun 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:30pm
8-K
e3al71ib
12 Apr 23
Regulation FD Disclosure
8:45am
8-K
nqdw74i
5 Apr 23
Departure of Directors or Certain Officers
4:25pm
8-K
vac4a2
23 Mar 23
Departure of Directors or Certain Officers
4:30pm